NASDAQ

Cue Biopharma, Inc.

CUE

1 article

$180M Market cap · 2026-08-20

CUE · short 2026-05-04

Cue Biopharma

Cue Biopharma faces a deteriorating balance sheet, recurring operating losses, ATM dilution and PIPE-investor selling pressure.